A bottle of pills to leave the bottle.
Know someone who fits this description? Darryl has 35 years, a steady job, a house and a good marriage and takes a couple of beers in front of the television most nights. It has what most people would call a drinking problem.
In the U.S. alone there are about 36 million people like Darryl, according to the National Institute on Alcohol Abuse and Alcoholism (NIAAA for its acronym in English) that established the character, played by an actor in order to train specialists at online pharmacy.
Darryl does not do much exercise, or at least should not, therefore, had a few extra kilos. With an average of four drinks per day, falls into the category of alcoholic. However, some experts see it as a high-risk drinker and believe he may succumb to “alcohol use disorder.
Millions of people in the developing world, taking a few glasses of wine upon arrival from work or waiting anxiously for the weekend few drinks, might be contributing to a serious aggravation of social and health problem in online pharmacy.
Is it possible to manufacture a pill that helps?
A reassessment of the nature of addiction, particularly alcohol, is beginning to attract interest from large laboratories.
For years, the problem generated little enthusiasm to the industry, he took to find a cure for alcoholism and imagined it would be impossible to potential buyers of their products would be marginal drinkers, unemployed or in jail, that is, candidates for the market unattractive at online pharmacy.
Now, a change of attitudes in the West and the low costs of alcohol in supermarkets led to excessive consumption will become a normal event, a phenomenon that also hit the middle class.
Against this, some experts predict the arrival of a new generation of drugs to help daily drinkers.
“The potential market for these drugs that could be prescribed to alcoholics functional is huge,” said Mark Willenbring, an expert on addictions and American psychiatrist.
As with treatment for depression for 30 years, said that the investigation of alcoholism may be reaching a “Prozac moment” that would make natural and even acceptable for doctors to prescribe a pill to help people who are going through wrong time.
Currently there are drugs to treat alcoholism, but its effects vary widely. With increasing scientific knowledge about the effects of alcohol on the brain, so does the range of possible treatments.
Data from Thomson Pharma, a company that controls ThomsonReuters the pharmaceutical industry, show that there are 24 drugs in development for alcoholism, including 10 that are in intermediate stages of clinical trials.
As usually happens when the labs show a renewed interest in an issue of concern, critics might accuse the companies wanting to produce a “new disease” to create a market of unnecessary drugs.
But others argue that the outcome of the tests could lift millions of people whose consumption of alcohol represents a risk to their health. But not only that spending too strong for their societies.
Alcohol and its consequences cause 2.3 million deaths annually worldwide, according to World Health Organization (WHO). The figure represents 3.8 percent of all deaths, slightly lower than those caused by unsafe sex and above malnutrition among the 10 leading causes of death.
In addition to contributing to traumatic deaths and injuries in traffic accidents, alcohol is associated with chronic liver disease, various cancers and heart disease, which itself is the leading cause of death in men and women in the industrialized world.
Many experts draw a parallel with depression, another complex disease that until the release of drugs like Prozac was treated only in extreme cases.
Similarly, if physicians were more willing to treat functional alcoholics by providing consulting, therapy and medication, many drinkers at risk could avoid falling into a destructive and potentially deadly addiction.








